戻る Agenda
Session 7: Track C: Leveraging Partnerships
Session Chair(s)
Loretta Del Bosco
Director, Regulatory Affairs Quality Assurance Operations, AbbVie Corporation, Canada
As the regulatory revisions and reforms evolve and the regulatory system strives to meet Canadian healthcare needs, new partnerships between related and unrelated stakeholders are forming. This session will allow for a better understanding and insight into the challenges and opportunities faced by various partnerships including Health Canada, HTAs, Third Parties, and Industry.
Learning Objective : At the conclusion of this session, participants should be able to:- Explain how strategic partnerships can accelerate product development
- Describe how creating new and building existing partnerships will strengthen the healthcare system in Canada
- Discuss the challenges and opportunities of partnerships in a transformational environment
Speaker(s)
Kelly Robinson, MSC
Director General, Pharmaceutical Drugs Directorate, Health Canada, Canada
Health Canada: Expanding Collaboration with Health Partners
Lauren Neighbours, PHD, RAC
Sr. Director and Head, Regulatory Affairs, Istari Oncology, United States
Help Me Help You: Strategic Partnerships to Streamline Product Development
Heather Logan
Vice-President, Pharmaceutical Reviews , Canadian Agency for Drugs and Technologies in Health, Canada
Building, Sustaining, and Enduring Partnerships: A New Kind of Math